Beranda › Melanoma › California › San Francisco
Uji klinis Melanoma di San Francisco, CA
22 studi untuk Melanoma mencari peserta di lokasi sekitar San Francisco (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Menerima pesertaFase 2
- UCSF Medical Center at Mission Bay ( Site 4044), San Francisco
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Menerima pesertaFase 3
- University of California San Francisco (UCSF), San Francisco
Intratumoral N17350 in Advanced Solid Tumors
Menerima pesertaFase 1/2
- University of California, San Francisco, San Francisco
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Menerima pesertaFase 2
- Local Institution - 0096, San Francisco
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Menerima pesertaFase 1/2
- University of California-San Fransisco, San Francisco
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Menerima pesertaFase 1/2
- University of California San Francisco, San Francisco
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- UCSF Medical Center-Mission Bay, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Menerima pesertaFase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Menerima pesertaFase 2
- University of California, San Francisco, San Francisco
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Menerima pesertaFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Menerima pesertaFase 3
- UCSF Wayne and Gladys Valley Center for Vision, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Menerima pesertaFase 1/2
- University of California San Francisco (UCSF), San Francisco
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Menerima pesertaFase 2/3
- UCSF, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Menerima pesertaFase 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Kaiser Permanente-San Francisco, San Francisco
ACTengine® IMA203 Combined With mRNA-4203
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Menerima pesertaFase 2
- California Pacific Medical Center - Sutter Health, San Francisco
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
Menerima pesertaStudi observasional
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Menerima pesertaFase 2
- University of California, San Francisco (UCSF), San Francisco
Uji klinis Melanoma di kota lain
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN33 studi
- Pittsburgh, PA31 studi
- Boston, MA26 studi
- Philadelphia, PA23 studi
- Columbus, OH21 studi
- Durham, NC21 studi
- Atlanta, GA21 studi
- Salt Lake City, UT21 studi
- St. Louis, MO21 studi
Studi lain di San Francisco
- Kanker Prostat45 studi
- Kanker Payudara43 studi
- Kanker Paru Non-Sel Kecil36 studi
- Kanker (semua jenis)35 studi
- Gagal Jantung29 studi
- Kanker Metastatik28 studi
- Kanker Paru22 studi
- Kanker Pankreas20 studi
- Kanker Ovarium19 studi
- Kanker Kolorektal18 studi
- Penyakit Kardiovaskular18 studi
- Glioblastoma17 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.